Tuesday, March 28, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biosecurity

Characterization and Countermeasures for Biological Toxins

by Global Biodefense Staff
August 3, 2015

The Defense Threat Reduction Agency (DTRA) is seeking sources of fundamental toxin characterization, and new or repurposed medical countermeasures (MCMs) against naturally-occurring biological toxins.

The Request for Information (RFI) supports future funding efforts by the agency’s chemical and biological defense programs.

DTRA seeks to assemble background characteristics, putative mechanism of action, toxicological implications and assessment, and identify candidate MCMs that have the potential to safely, potently and specifically protect against different classes of potent biological toxins capable of causing human death or incapacitation. Both pre- and post-exposure indications are included.

“Since biological toxins are diverse in origin, chemical structure and mechanism of action, this class of threat agents may require a variety of countermeasure strategies,” states the announcement. “DoD welcomes engagement of all qualified sources of technologies in the aforementioned domain.”

Further details are available via Solicitation Number: HDTRA1-15-RFI-CBM. The response deadline is Aug. 28, 2015.

Tags: AntitoxinsDefense Threat Reduction AgencyRFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
DARPA Selects Teams to Develop Vaccine Durability Prediction Model
Medical Countermeasures

DARPA Selects Teams to Develop Vaccine Durability Prediction Model

January 13, 2023
small glass vials on an assembly line await filling of vaccine solution
Industry News

Sabin Vaccine Institute to Advance Ebola Sudan and Marburg Vaccines with New BARDA Funding

January 12, 2023
How Are Bivalent COVID Vaccines Stacking Up Against Omicron?
Infectious Diseases

How Are Bivalent COVID Vaccines Stacking Up Against Omicron?

January 12, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC